Shows
BioBossVlad Vitoc - Founder and CEO of MAIA BiotechnologyVlad Vitoc, founder and CEO of MAIA Biotechnology, shares his insights with BioBoss host John Simboli about leadership in biopharma and how MAIA is working to develop and deliver innovative medicines to improve and extend the lives of people living with cancer.2025-02-2735 min
Beyond Biotech - the podcast from LabiotechTargeting telomerase to disrupt cancerTelomeres are structures made from DNA sequences and proteins, and they are found at the ends of chromosomes. In effect, they cap and protect the end of a chromosome. Telomerase is an enzyme that adds DNA to the ends of chromosomes, and it is reactivated in most cancers. Most human tumors not only express telomerase but also have very short telomeres. This makes telomerase a prime target for cancer therapies. MAIA Biotechnology is focused on the pioneering approach of telomere targeting through its lead therapeutic strategy, THIO. Currently, MAIA is making st...2024-10-0426 min
Life Science SuccessFrom Medicine to Biotech: Dr. Vitoc's Quest for Cancer BreakthroughsSend us a textIn this episode of the Life Science Success Podcast, my guest is Dr. Vlad Vitoc, Chairman of the Board, CEO, and President of MAIA Biotechnology. Dr. Vitoc shares his journey from practicing medicine in Romania to leading a cutting-edge biotech company in the United States. We explore MAIA Biotechnology's innovative approach to cancer treatment, focusing on telomere-targeting therapeutics and their lead compound, THIO. Dr. Vitoc offers insights into the challenges of developing new cancer therapies, the future of targeted treatments, and how his international background influences his leadership style. He also d...2024-09-2740 min
London FuturistsProgress with ending aging, with Aubrey de GreyOur topic in this episode is progress with ending aging. Our guest is the person who literally wrote the book on that subject, namely the book, “Ending Aging: The Rejuvenation Breakthroughs That Could Reverse Human Aging in Our Lifetime”. He is Aubrey de Grey, who describes himself in his Twitter biography as “spearheading the global crusade to defeat aging”.In pursuit of that objective, Aubrey co-founded the Methuselah Foundation in 2003, the SENS Research Foundation in 2009, and the LEV Foundation, that is the Longevity Escape Velocity Foundation, in 2022, where he serves as President and Chief Science Officer.Full...2024-04-2142 min
The ExecutiveNavigating an IPO in a Challenging Market: Vlad Vitoc, CEO of MAIA
Vlad Vitoc is the Founder & CEO of MAIA, an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. Vlad and his team took MAIA public successfully in 2022 in one of the most difficult IPO markets in recent years.
---
Send in a voice message: https://podcasters.spotify.com/pod/show/the-executive/message2023-03-3113 min